IVF Success Rates and Costs: What Fertility Clinics Don't Always Tell You
IVF success rates vary sharply by age and clinic. Learn real costs per cycle, factors that affect outcomes, and what fertility clinics may downplay.
Success Rates That Vary by 30 Percentage Points Depending on Age
In 2021, U.S. fertility clinics reported 413,776 IVF cycles to the Centers for Disease Control and Prevention's National ART Surveillance System (NASS) — the most rigorous national dataset on in vitro fertilization outcomes. The live birth rate per egg retrieval for patients using their own eggs ranged from 46.6% for women under 35 to just 3.9% for women aged 42–43. That gap defines one of the most important facts about IVF: age is the dominant variable in outcomes, and no clinic can fully overcome it.
IVF involves stimulating the ovaries with injectable hormones to produce multiple eggs, retrieving those eggs via a transvaginal ultrasound-guided needle, fertilizing them with sperm in a laboratory, and transferring one or more resulting embryos into the uterus. The first successful IVF birth — Louise Brown — occurred in 1978 in the UK. Today the procedure is practiced in over 60 countries.
How Success Rates Are Reported — and How to Read Them Carefully
The CDC publishes clinic-specific data, but comparing clinics based on raw success rates is misleading without adjustment. Clinics that accept more difficult cases (older patients, prior IVF failures, severe diagnoses) will have lower headline numbers than clinics that select younger or healthier patients.
Key distinctions in how rates are reported:
- Per retrieval vs. per transfer: "Per retrieval" includes all cycles that began, including those that produced no viable embryos. "Per transfer" only counts cycles that reached the transfer stage. Per-transfer rates are higher and sometimes used selectively in marketing
- Live birth vs. clinical pregnancy: A clinical pregnancy (heartbeat detected) is easier to achieve than a live birth. Clinics emphasizing "pregnancy rates" rather than "live birth rates" may appear more successful
- Frozen vs. fresh embryo transfers: Frozen embryo transfer (FET) cycles now account for the majority of transfers in the U.S. and generally show comparable or better outcomes than fresh transfers due to the ability to time the uterine lining optimally
- Donor eggs: Cycles using donor eggs have significantly higher success rates (around 40–50% live birth rate per transfer) because donor eggs typically come from younger women, and age-related egg quality issues are bypassed
| Patient Age (own eggs) | Live Births per Egg Retrieval (2021 NASS) | Live Births per Embryo Transfer (2021 NASS) |
|---|---|---|
| Under 35 | 46.6% | 51.9% |
| 35–37 | 37.3% | 43.1% |
| 38–40 | 24.3% | 31.5% |
| 41–42 | 12.9% | 19.1% |
| 43–44 | 5.9% | 10.9% |
| Over 44 | 2.2% | 5.5% |
Real Costs Per Cycle
The numbers are significant. A single IVF cycle in the United States costs between $12,000 and $25,000 when all components are included — a figure often higher than the base price quoted by clinics.
| Cost Component | Typical Range |
|---|---|
| Base IVF cycle fee (monitoring, retrieval, lab) | $8,000–$13,000 |
| Fertility medications (injectable gonadotropins) | $3,000–$6,000 |
| ICSI (intracytoplasmic sperm injection) | $1,000–$2,000 (if needed) |
| Preimplantation genetic testing (PGT-A) | $3,000–$6,000 |
| Embryo freezing and storage (first year) | $1,000–$2,000 |
| Frozen embryo transfer (FET) cycle | $3,000–$5,000 |
Only 19 U.S. states had some form of infertility insurance mandate as of 2024, though mandates vary in what they require and who they cover. Employer-sponsored coverage through large companies (Google, Apple, Amazon, and others) has expanded significantly in recent years, with some offering $20,000–$75,000 in lifetime fertility benefits.
What Clinics Don't Always Emphasize
Most patients need more than one cycle. The cumulative live birth rate after three complete cycles is substantially higher than after one — approximately 65% for women under 35, according to research published in the New England Journal of Medicine (Malizia et al., 2009, and subsequent studies). Cost projections should account for this probability.
- Preimplantation genetic testing for aneuploidy (PGT-A) reduces the chance of miscarriage and failed transfers from chromosomally abnormal embryos, but adds $3,000–$6,000 and requires at least one genetically normal embryo to transfer — not guaranteed
- Add-on treatments such as endometrial receptivity analysis (ERA), assisted hatching, and reproductive immunology panels are widely marketed but have limited or mixed evidence supporting improved outcomes
- Elective single embryo transfer (eSET) is increasingly recommended to reduce twin and triplet pregnancies, which carry significantly higher complication rates for mother and children
- Clinics that charge per cycle rather than offering multi-cycle packages may present different financial structures — multi-cycle packages sometimes include refund guarantees but often exclude high-risk patients
The Society for Assisted Reproductive Technology (SART) publishes annual clinic-specific data at sartcorsonline.com, adjusted for patient age, diagnosis, and other factors. Reviewing this data before selecting a clinic is recommended by most reproductive endocrinologists.
Emotional and Physical Demands
IVF is physically intensive. Patients self-administer subcutaneous injections of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) over 8–14 days, attend multiple monitoring appointments involving blood draws and transvaginal ultrasounds, and undergo egg retrieval under sedation. Ovarian hyperstimulation syndrome (OHSS) — a potentially serious complication — occurs in mild form in 10–20% of cycles and in severe form in roughly 1–2%.
- The psychological burden of IVF — particularly after failed cycles — is documented as comparable to that of cancer diagnosis in some studies
- Mental health support, offered at many fertility clinics, is widely recommended during and after treatment
- Success in the first cycle is not guaranteed; managing expectations while maintaining hope is a core challenge for patients and clinicians alike
This article is for informational purposes only. Consult a qualified healthcare professional before making medical decisions.
Related Articles
womens health
Autoimmune Diseases in Women: Why Women Are Disproportionately Affected
A detailed exploration of autoimmune diseases and their disproportionate impact on women, covering the most common conditions, the biological and hormonal reasons for this disparity, and approaches to diagnosis and management.
10 min read
womens health
Hormone Replacement Therapy for Menopause: Benefits, Risks, and Options
HRT remains the most effective treatment for menopause symptoms. Learn what the latest evidence says about benefits, risks, and which women are good candidates.
9 min read
womens health
How Breast Cancer Screening Methods Work: Mammography and Beyond
Compare breast cancer screening methods including mammography, ultrasound, MRI, and emerging technologies, plus current guidelines by risk level and age group.
9 min read
womens health
How Gestational Diabetes Affects Pregnancy and Future Health
Learn how gestational diabetes develops during pregnancy, its effects on mother and baby, screening methods, blood sugar management, and long-term health implications.
9 min read